INTERCEPT pathogen-reduced platelets are not associated with higher rates of alloimmunization with (or without) clinical refractoriness in published studies

Transfusion. 2020 Apr;60(4):881-882. doi: 10.1111/trf.15722.

Authors

Richard J Benjamin¹, Laurence Corash¹, Philip J Norris^{2

3}

Affiliations

¹ Cerus Corporation, Concord, California.
² Vitalant Research Institute, San Francisco, California.
³ Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California.

PMID: 32246477
DOI: 10.1111/trf.15722

No abstract available

Publication types

Letter

MeSH terms

Blood Platelets / immunology*
Blood Platelets / microbiology
Humans
Isoantibodies / immunology*
Platelet Transfusion / adverse effects

Substances

Isoantibodies